Ludger Sialic Acid Analysis

Quantitative Sialic Acid Release and DMB Labeling Kit

Sialic acid analysis workflow designed to satisfy the regulatory requirements for biopharmaceutical sialic acid content analysis to specify the following:

  1. Overall degree of drug sialylation - absolute quantitation of sialic acid residues per molecule (nmol/mg protein)
  2. Relative quantities of Neu5Ac:Neu5Gc
  3. Identification and relative percentage of O-acetylated sialic acids

Product/Ordering Information:

Release and label sialic acids with DMB:

  • LT-KDMB-A1
  • LudgerTag DMB sialic acid release and labeling kit
Ludger Quantitative Sialic Acid Release and DMB Labeling Kit

Each kit is suitable for analysing 22 samples, and contains the following:

  • DMB Dye  (LT-DMB-01)
  • Acetic Acid 2 Molar  (LT-ACETIC2M-01)
  • Mercaptoethanol in Acetic acid  (LT-MERCAPTO-01)
  • Sodium Dithionite (Reductant)  (LT-DITHIO-01)
  • N -acetylneuraminic acid (Neu5Ac or NANA) -- Quantitative Standard  (CM-NEU-AC-01)
  • N -glycolylneuraminic acid (Neu5Gc or NGNA) -- Quantitative Standard  (CM-NEU-GC-01)
  • Sialic Acid Reference Panel (containing Neu5Ac, Neu5Gc, Neu5,7Ac2, Neu5Gc,9Ac, Neu5,8Ac2, Neu5,9Ac2 and Neu5,x,xAc3 (where x is an unknown acetyl position)) (CM-SRP-01)

Companion Products:

Standards and Controls:

  • GCP-FET-50U-X4
  • Fetuin Glycoprotein -- Process Standard
  • BQ-GPEP-A2G2S2-10U
  • LudgerBioQuant GPEP A2G2S2 glycopeptide -- Quantitative Process Standard
  • CM-NEU5,9,AC2-01
  • 5-N -acetyl-9-O-acetyl neuraminic acid (Neu5,9Ac2) -- Reference Standard
  • *CM-NEU-AC-01
  • N -acetylneuraminic acid (Neu5Ac or NANA) -- Quantitative Standard
  • *CM-NEU-GC-01
  • N -glycolylneuraminic acid (Neu5Gc or NGNA) -- Quantitative Standard
  • *CM-SRP-01
  • Sialic acid reference panel -- System Suitability and Reference Standard
  • * there is 1 of each included in the kit, but if you require additional replicates they can be ordered separately.

HPLC Analysis:

  • LS-R1-4.6x150
  • LudgerSep R1 HPLC Column (hydrophobic chromatography column containing particles with an octadecylsilane coating)

UHPLC Analysis:

  • LS-UR2-2.1x100
  • LudgerSep uR2 UHPLC Column (hydrophobic chromatography column containing particles with an octadecylsilane coating)


Posters

Ludger ICS 2018 Glycan Standards poster

Glycan Standards as Key Tools for Robust and Reliable Analysis of Glycoproteins

Hendel J, Peel S, Spencer D
Presented at: 29th International Carbohydrate Symposium
Lisbon, Portugal. July 15-19th 2018

Awarded the Chemical Biology Poster Prize by the Royal Society of Chemistry's 'Organic & Biomolecular Chemistry' Journal

WCBP Sialic Acid Poster

Analysis of Sialic Acids in Biopharmaceuticals

Hendel J, Royle L, Kozak RP, Fernandes DL
Presented at:
WCBP 2017: 21st Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products
Washington D.C., United States. January 24-26th 2017


FAQs

In general we recommend against storing the left over solution because we cannot guarantee the chemical quality after storage. The reason that it is generally too risky to store this solution is that it contains a mixture of two reducing agents and a light sensitive dye – if this solution is not protected from the air (oxygen in the air with react with the reducing agents) and the light then the efficiency of the labelling reaction will be impacted and the quality of the resulting data will suffer. As this mixture is in an ampule – which is required for shipment and storage under inert atmosphere – and is now broken open there is no way to reseal unless you transfer the solution – we consider this too big a risk and potentially too variable of a process from lab to lab to suggest this to our clients as best practice.

Some salts/buffers commonly used with proteins may interfere with the sialic acid analysis process. This is dependent on the amount of sample taken compared to the volume of buffer (as a large amount of buffer can affect the acidity of the solution during acid hydrolysis). In our experience buffers such as PBS are not a problem where the sample concentrations are above 1mg/mL and between 50 and 200 µg of sample is taken for analysis. This will need to be tested for each sample type and we recommend a buffer blank also be taken though to the process to establish if there are any components in the buffer that interfere with the quantitation of sialic acids.

We have seen this happen before under 2 circumstances: 1) When the amount of protein in the sample is too high you can end up with a thick solution after acid treatment. We were able to solve this problem by using less starting material (you can run the assay with 50-200µg starting material). Consequently, if you find that your signal is too low when running the samples on LC, do not dilute them prior to injection. 2) Certain buffers can also lead to a thick solution. Our solution to this was to perform a buffer exchange into water prior to acid release. We use vivaspin cartridges with a molecular weight cut off of 10 kDa for buffer exchange.

We have tried to aliquot fetuin standards from one vial before and our data was also poor. It is best practice not to aliquot the standards but rather use them as provided. This is the only way to ensure that no sample is lost.

We have used this method with many formulation buffers and we have yet to encounter a problem. Regardless, we always run a buffer blank in order to establish if there are any potential interfering species.

Fetuin is a glycoprotein which has both NANA and NAGA. This standard has been studied well in our labs using the DMB assay and we have set acceptance criterion which is based on several years of historical data - this criterion is constantly being monitored and been updated as we collect more and more data about this standard.

GPEP is a glycopeptide with a biantennary disialylated glycan. This is a purified homogeneous glycopeptide that has been quantitated using qNMR. The acceptance criteria is set based on this qNMR value.

There are pros and cons to both standards. Fetuin is a glycoprotein which may match your own sample of interest better than a glycopeptide, however, the glycopeptide is quantified in a more robust way (since it is a smaller molecule that can be subject to NMR). Also, fetuin contains both sialic acids - which may be an important aspect for you, while, GPEP only has NANA. You will need to assess what is important for your assay - we always use both but this is a choice you will need to make for your specific situation.

In terms of sensitive steps to take into account – when we use this kit in-house or for client services the hitch points are often the following:

  1. Accurate transfer of 5ul of the sample from the acid release step for the labelling experiment. Considerable care should be taken because of the small volume transferred
  2. After adding the labelling reagents that the samples are mixed well
  3. Perhaps the step with the most opportunity to impact quantitation is when preparing the LC samples for analysis. These must be prepared with care and mixed very well to ensure a uniform solution is injected into the LC
  4. Also in general – protecting the labelled samples from degradation by exposure to light is important – provided that they weren’t left sitting out for an extended period of time they should be fine – this is easily identified as the samples tend to go pink in colour

We always run triplicates in order to ensure that the data we have is trustworthy. Especially with the quantitative assays it is easy to have some degree of operator error - for instance in this assay transferring 5ul for labelling is a pinch point. It allows the analyst to quickly see if there is an outlier


Contacts